CS logo
small CS logo
Tranquility Research

Webster, Texas, United States
Corporate office
16969 N Texas Ave Suite 600, Webster, TX 77598

About Tranquility Research


"Tranquil Clinical Research (CRO and Phase I Unit) was created to ensure that the entire clinical trial, device, and drug development process is conducted with ethics and the patient in mind first and always. TCR has a first of its kind patient centric inpatient Phase I Unit strategically located near the largest medical center in the world and in the most diverse city in the US and surrounded by 14 university/college systems."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Tranquility Research


During the past decade, Tranquility Research conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
2011-04-01
2023-07-01
Active, not recruiting
1,545
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
2011-01-06
Active, not recruiting
3,270
A Study Comparing Obinutuzumab (RO5072759; GA101) 1000 Milligram (mg) Versus 2000 mg in Participants With Previously Untreated Chronic Lymphocytic Leukemia (CLL) (GAGE)
2011-10-31
2016-03-31
Completed
80
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
2012-06-12
2023-06-30
Active, not recruiting
1,194
Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
2012-04-01
2023-11-01
Active, not recruiting
1,871
An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry)
2012-06-05
2017-11-16
Completed
1,007
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
2013-04-01
2030-01-01
Active, not recruiting
1,900
A Study of Weekly Carfilzomib in Combination With Dexamethasone for Progressive Multiple Myeloma
2012-07-04
2018-10-31
Completed
116

Rows per page:

1–69 of 69

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Tranquility Research" #1 sponsor was "Pfizer" with 3 trials, followed by "First Wave BioPharma, Inc." with 1 trials sponsored, "Goldfinch Bio, Inc." with 1 trials sponsored, "Navidea Biopharmaceuticals" with 1 trials sponsored and "Phanes Therapeutics" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Tranquility Research" #1 collaborator was "Oncobay Clinical, Inc" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Tranquility Research


According to Clinical.Site data, the most researched conditions in "Tranquility Research" are "COVID-19" (3 trials), "Advanced Cancer" (1 trials), "Advanced Solid Tumor" (1 trials), "Breast Adenocarcinoma" (1 trials) and "Colo-rectal Cancer" (1 trials). Many other conditions were trialed in "Tranquility Research" in a lesser frequency.

Clinical Trials Intervention Types at Tranquility Research


Most popular intervention types in "Tranquility Research" are "Drug" (8 trials). Other intervention types were less common.
The name of intervention was led by "PF-07321332" (3 trials), "Placebo" (3 trials), "Ritonavir" (3 trials), "Anti-PD-1 monoclonal antibody" (1 trials) and "GFB-887" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Tranquility Research


The vast majority of trials in "Tranquility Research" are 8 trials for "All" genders.

Clinical Trials Status at Tranquility Research


Currently, there are NaN active trials in "Tranquility Research". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Tranquility Research, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Tranquility Research, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status